These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 16210093)

  • 21. [Epigenome and cancer: new possibilities of cancer prevention and therapy?].
    Paluszczak J; Baer-Dubowska W
    Postepy Biochem; 2005; 51(3):244-50. PubMed ID: 16381168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic silencing of the MGMT gene in cancer.
    Soejima H; Zhao W; Mukai T
    Biochem Cell Biol; 2005 Aug; 83(4):429-37. PubMed ID: 16094446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Promoter hypermethylation and CpG island methylator phenotype in colorectal carcinogenesis].
    Matsubara N
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1659-64. PubMed ID: 20841928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypermethylation of gene promoters in hematological neoplasia.
    Chim CS; Liang R; Kwong YL
    Hematol Oncol; 2002 Dec; 20(4):167-76. PubMed ID: 12469326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies.
    Taniguchi H; Fernández AF; Setién F; Ropero S; Ballestar E; Villanueva A; Yamamoto H; Imai K; Shinomura Y; Esteller M
    Cancer Res; 2009 Nov; 69(21):8447-54. PubMed ID: 19861541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic mechanisms in glioblastoma multiforme.
    Nagarajan RP; Costello JF
    Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation immediately adjacent to active histone marking does not silence transcription.
    Brinkman AB; Pennings SW; Braliou GG; Rietveld LE; Stunnenberg HG
    Nucleic Acids Res; 2007; 35(3):801-11. PubMed ID: 17202157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA hypermethylation: when tumour suppressor genes go silent.
    Garinis GA; Patrinos GP; Spanakis NE; Menounos PG
    Hum Genet; 2002 Aug; 111(2):115-27. PubMed ID: 12189484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-talk between aging and cancer: the epigenetic language.
    Fraga MF; Agrelo R; Esteller M
    Ann N Y Acad Sci; 2007 Apr; 1100():60-74. PubMed ID: 17460165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant gene silencing in tumor progression: implications for control of cancer.
    Baylin SB; Chen WY
    Cold Spring Harb Symp Quant Biol; 2005; 70():427-33. PubMed ID: 16869780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic silencing of the sulfotransferase 1A1 gene by hypermethylation in breast tissue.
    Kwon MS; Kim SJ; Lee SY; Jeong JH; Lee ES; Kang HS
    Oncol Rep; 2006 Jan; 15(1):27-32. PubMed ID: 16328031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation: the nuts and bolts of repression.
    Miranda TB; Jones PA
    J Cell Physiol; 2007 Nov; 213(2):384-90. PubMed ID: 17708532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
    Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger.
    Ballestar E; Esteller M
    Biochem Cell Biol; 2005 Jun; 83(3):374-84. PubMed ID: 15959563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
    Li LC; Carroll PR; Dahiya R
    J Natl Cancer Inst; 2005 Jan; 97(2):103-15. PubMed ID: 15657340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The epigenetics of oral cancer.
    Shaw R
    Int J Oral Maxillofac Surg; 2006 Feb; 35(2):101-8. PubMed ID: 16154320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic gene silencing in acute promyelocytic leukemia.
    Villa R; De Santis F; Gutierrez A; Minucci S; Pelicci PG; Di Croce L
    Biochem Pharmacol; 2004 Sep; 68(6):1247-54. PubMed ID: 15313423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [DNA methylation: an epigenetic process of medical importance].
    Rodríguez-Dorantes M; Téllez-Ascencio N; Cerbón MA; López M; Cervantes A
    Rev Invest Clin; 2004; 56(1):56-71. PubMed ID: 15144044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation and hepatocellular carcinoma.
    Zhu J
    J Hepatobiliary Pancreat Surg; 2006; 13(4):265-73. PubMed ID: 16858536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.